Professor Gordon Howarth
Professor
School of Animal and Veterinary Science
Faculty of Sciences, Engineering and Technology
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Professor Gordon Howarth leads the University of Adelaide’s Digestive Health Research Group and was continuously supported by Cancer Council Australia Senior Research Fellowships from 2005 to 2014. He also holds Affiliate Professor status in the Gastroenterology Department of the Women’s and Children’s Hospital.
- My Research
- Career
- Publications
- Grants and Funding
- Teaching
- Supervision
- Professional Activities
- Contact
Professor Howarth's research focuses on understanding the mechanisms by which newly-identified bioactive agents act in the intestine. These bioactive agents include probiotics, probiotic-sourced bioactives, prebiotics, synbiotics and bioactive extracts of plant, animal and marine origin. Dr Howarth has developed a wide range of animal models of gastrointestinal disease over a 20-year period. These include models of gastric ulceration, NSAID-enteropathy, chemotherapy-induced mucositis, radiation enteritis, the inflammatory bowel diseases Crohn's disease and ulcerative colitis, and colon cancer. He has utilized these models to demonstrate therapeutic applications for a number of growth factors (eg IGF-I, the subject of Professor Howarth's PhD studies) and bioactive formulations including a whey-derived growth factor extract that is currently undergoing clinical trial for the treatment of oral mucositis. Although Professor Howarth has been an Affiliate title-holder in the University for many years, he joined the University of Adelaide as an Associate Professor in the Discipline of Agricultural and Animal Science in early 2006.
Professor Howarth was supported by Senior Research Fellowships from the Cancer Council for the period 2005-2014. Specific areas of research in the Howarth laboratory include:
- Application of probiotics and probiotic-sourced factors for prevention of bowel inflammation
- The role of medium-chain fatty acids in the development of colon cancer
- Effects of chemotherapy agents on intestinal stem cell expression
- Effects of new bioactive agents on intestinal stem cell expression
- Determining potential efficacy of prebiotics such as FOS/GOS in models of intestinal mucositis and inflammatory bowel disease
- Determining potential efficacy of newly-identified bioactives including dipeptidyl peptidase inhibitors, marine and land mollusc-sourced extracts, wine-sourced procyanidins and herbal extracts for treatment of intestinal mucositis, inflammatory bowel disease and other bowel disorders
- Gut function analyses of congenital disorders such as mucopolysaccharidosis
- Determining gene expression profiles in the intestine
- Nutraceutical modification of animal diets to improve growth performance and animal welfare
Composition of Digestive Health Research Group
Professor Howarth currently leads a team of 22 researchers carrying out novel techniques to assess new treatment strategies for gastrointestinal disease utilising established in vivo model systems. Professor Howarth plays a key role in conceptualisation of research that is undertaken. With respect to his primary research interests, particularly the novel bioactive and animal model studies, he is clearly identified as the principal originator of this research. Moreover, he fulfils the role of a mentor to post-doctoral, research assistant and technical support staff in addition to providing career guidance and counselling to under-graduate, Honours and PhD students. Professor Howarth currently has full access to excellent laboratory space and equipment resources at the Women's and Children's Hospital Gastroenterology Department and at the Roseworthy campus of the University of Adelaide.
Research Collaborations
Professor Howarth has developed and established a significant number of collaborations with other researchers with similar interests in pre-clinical development of bioactive factors for treatment of intestinal disease, or with different applications and hypotheses that require similar technological solutions. The table below lists the collaborations, both with industry and with other researchers, with which he has been involved, with a level of involvement ranging from:
- Providing technical expertise on experimental conditions and analyses required to establish identified animal models of GI disease, or answer questions outside of my direct area of research interest;
- A contribution to the study design, interpretation of data and drafting of manuscripts, or
- Hands-on performance of research studies.
Chief Collaborator | Institutions | Status | Details Of Project | Level Of Involvement | Industry Partners |
---|---|---|---|---|---|
Dr Ron Cox |
CSIRO, Sydney NSW |
Completed/ 1984 |
Development of a radio-receptor assay for detection of hormone receptors on breast tumours |
Methodological expertise |
|
Professor Mathew Vadas |
Institute of Medical and Veterinary Science, Adelaide |
Completed/ 1987 |
Development of a new sensitive assay for anti-nuclear antibodies in human sera |
Methodological expertise |
|
Dr John Ballard |
CRC for Tissue Growth and Repair |
Completed/ 1995 |
Identification of insulin-like growth factor-I (IGF-I) as a potent growth stimulator in the gastrointestinal tract |
Methodological expertise |
GroPep Pty Ltd |
Dr Chris Goddard |
CRC for Tissue Growth and Repair |
Completed/ 1999 |
Investigations into the physiological role of betacellulin |
Methodological expertise |
GroPep Pty Ltd |
Mr Tony Scammell |
Northfield Laboratories, Adelaide |
Completed/ 1999 |
Whey-derived growth factors and treatment of inflammatory bowel disease |
Methodological expertise |
Nutricia Inc |
Dr Leanna Read |
CRC for Tissue Growth and Repair |
Completed/ 2002 |
Whey-derived growth factors and treatment of mucositis |
Methodological expertise |
TGR BioSciences Pty Ltd |
Dr Anne Donnet-Hughes |
Nestle Inc |
Completed/ 2002 |
Effects of milk growth factors on gut immaturity |
Methodological expertise |
Nestle Inc |
Dr Leanna Read |
TGR BioSciences |
Completed/ 2003 |
Milk growth factors and treatment of gastric ulceration |
Methodological expertise |
TGR BioSciences Pty Ltd |
Dr Barry Powell |
Child Health Research Institute |
Completed/ 2004 |
Development of a screening assay for intestinal barrier function |
Methodological expertise |
Nestle Inc |
Dr Cathy Abbott |
Flinders University |
Completed/ 2006 |
The role of dipeptidyl peptidase IV in inflammatory bowel disease |
Methodological expertise |
Probiodrug Pty Ltd |
Dr Phil Giffard |
Queensland University of Technology |
Completed/ 2006 |
Probiotic and prebiotic interactions in gastrointestinal disease |
Methodological expertise |
|
Professor Peter Howe |
University of South Australia |
Completed/ 2007 |
Anti-inflammatory lipids and gastrointestinal disease |
Methodological expertise |
Pharmalink Pty Ltd |
Mr Chris Booton |
Nidor Pty Ltd |
Completed/ 2008 |
Development of the sucrose breath test of intestinal function |
Methodological expertise |
Nidor Pty Ltd |
Dr Marianne Hellers |
BioInnovation SA |
Completed/ 2006 |
In vivo models of GI disease |
Study design |
|
Dr Tony Clarkson |
Royal Adelaide Hospital |
Completed/ 1988 |
Aetiology of IgA Nephropathy |
Methodological expertise |
|
Dr Kym Bannister |
Royal Adelaide Hospital |
Completed/ 1982 |
Studies on aetiology of Membranous Glomerulonephritis |
Methodological expertise |
|
Dr Carlos-George Nascimento |
UCLA Davis, California |
Completed/ 1993 |
Epidermal Growth Factor (EGF) and protection of the intestine |
Methodological expertise |
|
Dr Cuong Tran |
Women’s & Children’s Hosp. |
Completed/ 2012 |
Effects of zinc supplementation on gastrointestinal disease |
Methodological expertise |
|
Dr Michael Conlon |
CSIRO Division of Human Nutrition |
Completed/ 1995 |
Insulin-like growth factors-I (IGF-I) and –II (IGF-II) and gastrointestinal growth in rats and guinea pigs |
Methodological expertise |
|
Dr Rob Fraser |
Dept of Radiation Oncology, Royal Adelaide Hospital |
Completed/ 2000 |
Insulin-like growth factors-I (IGF-I) and radiation enteritis |
Methodological expertise |
|
Dr Cory Xian |
Dept of Orthopaedics, Women’s and Children’s Hospital |
Completed/ 2000 |
Role of IGF-I, HGF and trefoil peptides in intestinal mucositis |
Methodological expertise |
|
Dr Art Hohmann and Dr Cory Xian |
Child Health Research Institute |
Completed/ 2000 |
Roles of IGF-I, TGFs and co-stimulatory molecules in acute, chronic and pre-neoplastic inflammatory bowel disease |
Methodological expertise
|
|
Dr Peter Coyle |
Inst of Medical and Veterinary Science, Adelaide |
Completed/ 2000 |
Role of zinc and metallothionein in intestinal disease |
Methodological expertise |
|
A/Prof Ashley Blackshaw |
Nerve-Gut Lab Hanson Institute |
Completed/ 2000 |
Effects of inflammation on bowel innervation |
Methodological expertise |
|
Prof Cory Xian |
Sansom Institute, University of South Australia |
Completed/ 2012 |
Chemotherapy-induced mucositis and bone disease |
Study design |
|
Dr Aleta Knowles |
Elanco Services (Eli Lilly), Vic; Melbourne |
Completed/ 2006 |
Spinosad and repair of chemotherapy-induced mucositis |
Methodological expertise |
Elanco Services (Eli Lilly), Vic; Melbourne |
Dr Claire Roberts |
Dept of Obstetrics and Gynaecology, University of Adelaide |
Completed/ 2005 |
IGF-I and IGF-II: effects on intra-uterine growth retardation in guinea pigs |
Methodological expertise |
|
Dr Sharon Byers |
Dept of Chemical Pathology, Women’s and Children’s Hospital, Adelaide |
Current Commenced/ January 2005 |
Effects of new treatments for mucopolysaccharidosis on the gastrointestinal tract |
Methodological expertise |
|
Dr Kathy Lee |
Dept of General Medicine, Women’s and Children’s Hospital, Adelaide |
Completed/ |
Hypertonic saline and treatment of bronchiolitis in neonates |
Study design
|
|
Mr John Waitzer |
Queensland University |
Completed/ |
Effects of Lyprinol on intestinal mucositis |
Methodological expertise
|
Pharmalink Pty Ltd. Brisbane, Queensland. |
Dr Bob Hughes
|
|
Current |
Effects of probiotics and prebiotics on intestinal function in poultry |
Methodological expertise
|
SARDI Poultry CRC |
Dr Ric van Tol
|
|
Completed/ |
Effects of new bioactives in a rat model of HIV infection |
Methodological expertise |
Numico Pty Ltd |
Mr Chris Gregory
|
|
Current |
Effects of Emu Oil on chemotherapy-induced mucositis |
Methodological expertise |
Emu Tracks |
Dr Roger Campbell |
|
Completed/ |
Effects of probiotics and prebiotics on intestinal function in pigs |
Methodological expertise |
SARDI Pork CRC |
Dr Luis Borges
|
|
Completed |
Effects of Palifermin on chemotherapy-induced mucositis |
Methodological expertise |
Amgen Inc |
Dr Adrian Cummins
|
Queen Elizabeth Hospital |
Current |
Effects of probiotics on intestinal stem-cell expression in chemotherapy-induced mucositis |
Methodological expertise |
|
Dr Susan Bastian
|
University of Adelaide (Oenology) |
Current |
Effects of grape seed extract on chemotherapy-induced mucositis and inflammatory bowel disease |
Methodological expertise |
|
A/Prof Christine Feinle-Bisset
|
Royal Adelaide Hospital |
Completed/ |
Effects of Iberogast on chemotherapy-induced mucositis and inflammatory bowel disease |
Methodological expertise |
|
Dr Luby Simson
|
University of Canberra |
Completed/ |
Effects of mistletoe extract on intestinal disease |
Methodological expertise |
|
Prof Andrea Yool
|
University of Adelaide (Physiology) |
Current |
Effects of rhubarb extract on aquaporin channels in inflammatory bowel disease |
Methodological expertise |
|
Dr Lindsay Burns
|
Pain Therapeutics |
Completed/ |
Effects of new analgesic agents on inflammatory bowel disease |
Methodological expertise |
|
Prof Allison Cowin Dr Zlatko Kopecki |
University of South Australia |
Current |
Effects of new bioactive agents on bowel inflammation in a model of epidermolysis bullosa |
Methodological expertise |
|
Dr David Stone
|
SARDI Flinders University |
Current |
Effects of new probiotics and prebiotics on abalone growth |
Methodological expertise |
|
Dr Cuong Tran |
CSIRO |
Commenced/ |
Effects of zinc supplementation on gastrointestinal disease |
Methodological expertise |
|
Dr Michael Story |
Story Pharmaceuticals |
Commenced/ |
Zinc Monoglycerolate and Emu Oil for treatment of inflammatory bowel diseases |
Methodological expertise |
Emu Tracks Pty Ltd |
Dr Roger Yazbek
|
Flinders University |
Commenced/ |
Volatile organic compounds in breath as markers of systemic disease |
Methodological expertise |
|
Dr Suzanne Mashtoub |
University of Western Australia |
Commenced/ |
Effects of Emu Oil on inflammatory bowel disease and colon cancer |
Methodological expertise |
|
Dr James Munro Prof Mary Barton |
University of South Australia |
Commenced/ |
Bacteriophage treatment of water supplies to prevent infectious diarrhoea |
Methodological expertise |
|
Dr Philip Marshall |
ORIL Pty Ltd |
Commenced/2016 |
Testing new anti-colon cancer compounds |
Methodological expertise |
|
Research Experience and Research Goals - Bioactive factors and Gastrointestinal Disease
Utilising in vivo animal model systems, our group was the first to identify insulin-like growth factor-I (IGF-I) as a potent growth factor for the small intestine. Since this discovery, I have been responsible for the development and evolution of animal model systems and novel methodologies that have provided new insights into the mechanisms of growth factor action in vivo . I have been invited to review the role of growth factors in the gastrointestinal tract in the Current Opinion series and Journal of Nutrition. To this end, I have previously investigated the clinical and nutraceutical application of growth factors including epidermal growth factor, IGF-I, IGF-II, transforming growth factor-a, transforming growth factor-b, hepatocyte growth factor, trefoil factors and betacellulin in addition to other agents, such as zinc and whey-derived growth factors. Since 2005 I have broadened my research interests to include mechanistic and pre-clinical studies of naturally-sourced bioactive agents including plant-extracts, marine extracts and probiotics, this culminating in successful grant awards from NHMRC in 2008 and RIRDC in 2009.
I am fully aware of the imperatives for research translation and commercial application of research and have previously utilised model systems of chemotherapy-induced mucositis to test the therapeutic application of a whey-derived growth factor extract. A Phase 1b clinical trial of this extract for treatment of oral mucositis was completed successfully through Melbourne’s Peter MacCallum Cancer Institute in 2002 and Phase IIb studies were completed in February 2008. I am the co-inventor of this treatment and international patents have now been granted. I have used in vivo model systems to test fundamental mechanistic hypotheses relating to the processes of intestinal protection, injury, repair, inflammation and transformation. To date we have developed models of gut immaturity, oral mucositis, gastritis, gastric ulceration, H pylori infection, NSAID-enteropathy, radiation enteritis, chemotherapy-induced mucositis, Crohn’s disease, ulcerative colitis and colonic carcinoma. This repertoire of animal models and associated novel analytical methods, which is available to other researchers, is a valuable resource that is unique in Australia, and possibly, the world. The primary aim of my future research ventures is to further our understanding of nutrition, and the importance of bioactive dietary supplementation in animals and humans, specifically as this relates to diseases and disorders of the gastrointestinal system. I am in the process of expanding my previous research on bioactive factors and the gut to include modulation of the glucagon-like peptide 2 (GLP-2)/dipeptidyl peptidase IV (DPIV) axis in addition to the investigation of probiotics, prebiotics and other naturally-sourced bioactive factors, for the prevention and treatment of gastrointestinal conditions such as intestinal mucositis and inflammatory bowel disease. My current research focuses on the recent development of non-invasive techniques to assess functions of the intestine, including absorption and indicators of intestinal transit, inflammation and ulceration. Although our group has only recently begun investigations into this exciting new research area, we have already been successful in attracting a $500,000 Biotechnology Innovation Fund grant for development of one of the tests (the sucrose breath test - SBT), becoming the first group to describe the SBT and its applicability to intestinal disease.
-
Appointments
Date Position Institution name 2015 - ongoing Associate Dean University of Adelaide 2010 - ongoing Professor University of Adelaide 2010 - ongoing Affiliate Professor Women's and Children's Hospital 2004 - 2010 Affiliate Associate Professor Flinders University 2003 - ongoing Affiliate Senior Scientist University of South Australia 2003 - 2009 Adjunct Professor University of South Australia 2002 - 2010 Affiliate Associate Professor Women's and Children's Hospital 2001 - ongoing Visiting Research Fellow University of Adelaide -
Education
Date Institution name Country Title 2001 - 2002 University of Adelaide Australia PhD 1976 - 1976 University of Adelaide Australia B Sc (Hons) 1973 - 1975 University of Adelaide Australia B Sc -
Certifications
Date Title Institution name Country 2006 Fellow American Gastroenterological Association United States 2004 Associate Member Royal College of Pathologists of Australasia Australia -
Research Interests
-
Journals
-
Book Chapters
Year Citation 2010 Prisciandaro, L., Howarth, G., & Geier, M. (2010). Priobiotics and prebiotics in inflammatory bowel disease. In S. Cho, & T. Finocchiaro (Eds.), Handbook of Prebiotics and Probiotics Ingredients (1 ed., pp. 233-258). Florida, USA: CRC Press. 2009 Prisciandaro, L., Howarth, G. S., & Geier, M. S. (2009). Probiotics and prebiotics in inflammatory bowel disease. In Handbook of Prebiotics and Probiotics Ingredients: Health Benefits and Food Applications (pp. 233-258).
Scopus22003 Brierley, S., Coldwell, J., Isaacs, N., Howarth, G., & Blackshaw, L. (2003). Colonic spinal primary afferents: mechanosensory and chemosensory subtypes and effects of inflammation. In G. Holtmann, & N. Talley (Eds.), Falk Symposium 130 - Gastrointestinal inflammation and disturbed gut function - the challenge of new concepts (Vol. 130, pp. 120-125). PO Box 17, 3300AA Dordrecht, The Netherlands: Kluwer Academic Publishers. -
Conference Papers
Year Citation 2023 Mashtoub, S., Maiolo, K., Chartier, L., Trinder, D., Lawrence, I., Barker, S., . . . Howarth, G. (2023). Emu oil reduces proximal colonic crypt hyperplasia in a murine model of colitis-associated colorectal cancer. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 106). WILEY. 2023 Kennewell, T., Mhlanga, S., Howarth, G., Chartier, L., Fujino, J., Mitchell, C., . . . Mashtoub, S. (2023). Kampo medicine (orengedokuto) improves stool consistency in a mouse model of 5-fluorouracil-induced mucositis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 38 (pp. 200). WILEY. 2022 Ndukwe, S., Wanner, K., Mitchell, C., Chartier, L., Howarth, G., & Mashtoub, S. (2022). Emu oil-modulated fecal microbiota transplantation reduces histologically assessed disease severity in a mouse model of Crohn's-like colitis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 105-106). WILEY. 2019 Jatmiko, Y. D., Howarth, G. S., & Barton, M. D. (2019). Evaluation of Yeast Diversity in Dadih and Dangke Using PCR-RFLP of Internal Transcribed Spacer Region. In IOP Conference Series: Earth and Environmental Science Vol. 391 (pp. 1-11). online: IOP Publishing.
DOI Scopus42018 Jatmiko, Y., Howarth, G., & Barton, M. (2018). Naturally fermented milk and its therapeutic potential in the treatment of inflammatory intestinal disorders. In AIP Conference Proceedings Vol. 2019 (pp. 060009-1-060009-16). Malang City, Indonesia: AMER INST PHYSICS.
DOI Scopus9 WoS52018 Chartier, L. C., Maiolo, K. E., Howarth, G. S., Lawrance, I., Trinder, D., Barker, S. J., . . . Mashtoub, S. (2018). EMU OIL IMPROVES CLINICAL INDICATORS OF DISEASE AND REDUCES PROXIMAL COLONIC CRYPT HYPERPLASIA IN A MURINE MODEL OF COLITIS-ASSOCIATED COLORECTAL CANCER. In GASTROENTEROLOGY Vol. 154 (pp. S875). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS22017 Barker, T. H., George, R. P., Howarth, G. S., & Whittaker, A. L. (2017). The Assessment of Housing Density and Social Hierarchy of Laboratory Rats on Behavioural Measures to Assess Welfare. In 2017 Australian & New Zealand Council for the Care of Animals in Research and Teaching Conference, ‘Maintaining Social License in a Changing World’. Queenstown, New Zealand. 2017 Jatmiko, Y., Howarth, G., & Barton, M. (2017). Assessment of probiotic properties of lactic acid bacteria isolated from Indonesian naturally fermented milk. In C. Salunkhe, A. Kikuchi, B. Govinda, Y. Jatmiko, & D. Siswanto (Eds.), AIP Conference Proceedings Vol. 1908 (pp. 050008-1-050008-14). Malang, Indonesia: AIP.
DOI Scopus17 WoS82016 Barker, T. H., Howarth, G. S., & Whittaker, A. L. (2016). Judgement Biases: Metabolic cage housing and sex effects. In Applied Animal Behaviour Science. Adelaide, South Australia: Elsevier BV. 2016 Bajic, J., Whittaker, A., Bobrovskaya, L., Hutchinson, M., & Howarth, G. (2016). Intestinal mucositis induced by 5-Fluorouracil results in glial changes modified by analgesics via neuro-immune mechanisms. In Australian Society for Medical Research. Adelaide. 2016 Whittaker, A. L., Bajic, J. E., Bobrovskaya, L., Hutchinson, M. R., & Howarth, G. S. (2016). Chemotherapy Induces Intestinal Inflammation and Central Changes Which Are Modified by Analgesics via Neuro-Immune Mechanisms. In GASTROENTEROLOGY Vol. 150 (pp. S52). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
DOI2014 Cheah, K. Y., Howarth, G. S., Bindon, K. A., Kennedy, J. A., Mashtoub, S., & Bastian, S. E. (2014). Low Molecular Weight Procyanidins From Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Colon Cancer Cells. In GASTROENTEROLOGY Vol. 146 (pp. S341). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
WoS12011 Woenig, J. A., Gower, P. K., Howarth, G. S., Roberts-Thomson, I. C., & Cummins, A. G. (2011). Inhibition of Notch Signalling Decreases Crypt Fission but Increases Apoptosis of Crypt Cells in the Small Intestine of the Infant Rat. In GASTROENTEROLOGY Vol. 140 (pp. S472). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2010 Yazbeck, R., Howarth, G. S., Butler, R. N., Geier, M. S., & Abbott, C. A. (2010). Dipeptidyl Peptidase-IV Inhibitors and Small Intestinal Adaptation During Experimental Colitis. In GASTROENTEROLOGY Vol. 138 (pp. S429). W B SAUNDERS CO-ELSEVIER INC. 2009 Xian, C. J., Fan, C. M., Cool, J. C., Scherer, M. A., King, T., Georgiou, K., . . . Foster, B. K. (2009). Pathophysiology and prevention of cancer chemotherapy-induced bone growth defects. In BONE Vol. 45 (pp. S103). Cambridge, ENGLAND: ELSEVIER SCIENCE INC.
DOI2009 Prisciandaro, L., Geier, M., Butler, R., Cummins, A., & Howarth, G. (2009). Compounds secreted from Escherichia Coli Nissle 1917, Streptococcus Thermophilus Th-4 and Lactobacillus Fermentum Br11 maintain intestinal cell viability following 5-fluorouracil administration in vitro. In Abstracts of the 2009 International MASCC/ISOO Syposium Vol. 17 (pp. 913-914). Italy: Springer.
DOI2009 Cheah, K., Bastian, S., Acott, T., & Howarth, G. (2009). Grape seed extract: effects on chemotherapy-induced mucositis and inflammatory bowel disease in rats. In Proceedings of the 2009 International MASCC/ISOO Syposium (pp. 905-906). Italy: Springer.
DOI2009 Prisciandaro, L., Geier, M., Butler, R., Cummins, A., & Howarth, G. (2009). Factors secreted from Lactobacillus fermentum Br11 and Escherichia Coli Nissle 1917 as a potential therapy for 5-fluorouracil induced mucositis: a pilot study. In Abstracts of the 2009 International MASCC/ISOO Symposium (pp. 913-914). Italy: Springer.
DOI2009 Mashtoub, S., Lindsay, R., Lymn, K., Geier, M., Butler, R., & Howarth, G. (2009). Emu oil improves parameters of intestinal integrity in rat models of inflammatory bowel disease and intestinal mucositis. In Abstracts of the 2009 International MASCC/ISOO Symposium (pp. 910-911). Italy: Springer.
DOI2009 Tran, C., Sundar, S., Howarth, G., & Butler, R. (2009). Use of the 13C-sucrose breath test to assess small bowel integrity in methotrexate-induced mucositis following zinc supplementation in metallothionein-knockout and wild-type mice. In Journal of Gastroenterology and Hepatology (pp. 328). Australia: Wiley-Blackwell.
DOI2009 Fauser, J., Butler, R., Cummins, A., Matthews, G., & Howarth, G. (2009). Modulation of the intracellular redox state induces apoptosis in the Caco-2 cell line. In Journal of Gastroenterology and Hepatology Vol. 24 (pp. 0 pages). Australia: Wiley-Blackwell.
DOI2009 Prisciandaro, L., Geier, M., Butler, R., Cummins, A., Howarth, G., & Abbott, C. (2009). Probiotic factors protect intestinal cells from chemotherapy-induced cytotoxicity and improve parameters of 5-fluorouracil induced intestinal mucositis in rats. In Journal of Gastroenterology and Hepatology Vol. 24 (pp. 328). Australia: Wiley-Blackwell.
DOI2009 Yazbek, R., Howarth, G., Butler, R., Geier, M., & Abbott, C. (2009). Dipeptidyl peptidase-IV inhibitors and small intestinal adaptation during experimental colitis. In Journal of Gastroenterology and Hepatology Vol. 24 (pp. 0 pages). Australia: Wiley-Blackwell.
DOI2007 Price, T. J., Morelli, L., Howarth, G. S., Webster, J., Zacharakis, B., Brooker, C., . . . Butler, R. N. (2007). Residual damage to the small intestine induced by chemotherapy can be detected and monitored using the non-invasive <SUP>13</SUP>C Sucrose Breath Test (SBT). In EJC SUPPLEMENTS Vol. 5 (pp. 152). Barcelona, SPAIN: PERGAMON-ELSEVIER SCIENCE LTD.
DOI2007 Torres, D. M., Butler, R. N., & Howarth, G. S. (2007). Lyprinol™ partially ameliorates 5-fluorouracil (5-FU)-induced mucositis in the rat. In GASTROENTEROLOGY Vol. 132 (pp. A570-A571). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2007 Yazbeck, R., Howarth, G. S., Demuth, H. U., Holst, J. J., & Abbott, C. A. (2007). Inhibition of dipeptidyl peptidase activity increases circulating glucagon-like peptide-2 and decreases neutrophil infiltration during experimental colitis in mice. In GASTROENTEROLOGY Vol. 132 (pp. A369-A370). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS22007 Forder, R., Howarth, G. S., Tivey, D. R., & Hughes, R. J. (2007). Changes in ileal mucin composition through interactions with intestinal microflora during early post-hatch development of poultry. In GASTROENTEROLOGY Vol. 132 (pp. A551). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2007 Smith, C. L., Geier, M. S., Butler, R. N., & Howarth, G. S. (2007). Dextran sulfate sodium-induced Crypt hyperplasia in the jejunum and ileum is prevented by oral administration of <i>Lactobacillus Fermentum</i> Br11 and <i>Bifidobacterium Lactis</i> Bb12 to rats. In GASTROENTEROLOGY Vol. 132 (pp. A370). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2007 Smith, C. L., Butler, R. N., & Howarth, G. S. (2007). <i>Lactobacillus fermentum</i> Br11 and fructo-oligosaccharide partially reduce jejunal inflammation but not overall damage severity of 5-fluoro-uracil-induced mucositis in rats. In GASTROENTEROLOGY Vol. 132 (pp. A714). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2007 Tran, C. D., Ball, J., Sundar, S., & Howarth, G. S. (2007). The role of zinc (Zn) and metallothionein (MT) in dextran sulfate sodium (DSS)-induced colitis in MT-null (MT-/-) and wild-type mice. In FASEB JOURNAL Vol. 21 (pp. A1120). Washington, DC: FEDERATION AMER SOC EXP BIOL.
WoS12006 Yazbeck, R., Sulda, M. L., Howarth, G. S., & Abbott, C. A. (2006). Dipeptidyl peptidases and their expression in a murine model of experimental. In GASTROENTEROLOGY Vol. 130 (pp. A347). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. 2006 Yazbeck, R., Abbott, C. A., Howarth, G. S., & Demuth, H. -U. (2006). Inhibition of dipeptidyl peptidase activity in DPIV knock-out mice and wild type mice decreases disease activity in experimental colitis. In GASTROENTEROLOGY Vol. 130 (pp. A345). Los Angeles, CA: W B SAUNDERS CO-ELSEVIER INC. 2006 Howarth, G. (2006). Probiotics and inflammatory bowel disease. In Emerging issues in inflammatory bowel diseases: proceedings of the Falk Symposium 151 held in Sydney, Australia, March 24-25, 2006 Vol. 151 (pp. 281-295). Sydney, NSW, Australia: Springer. 2005 Howarth, G. S., Inglis, K. L., Davidson, G. P., & Butler, R. N. (2005). The Sucrose Breath Test (sbt): a simple, rapid, non-invasive method to assess intestinal mucositis induced by different classes of chemotherapy drugs.. In GASTROENTEROLOGY Vol. 128 (pp. A552). Chicago, IL: W B SAUNDERS CO. 2005 Kamil, R., Butler, R., Geier, M. S., & Howarth, G. (2005). <i>Lactobacillus GG</i> but not Bifidobacterium BB12 increases severity of Indomathacin-induced intestinal ulceration in rats. In GASTROENTEROLOGY Vol. 128 (pp. A604). Chicago, IL: W B SAUNDERS CO.
WoS22005 Geier, M. S., Butler, R. N., & Howarth, G. S. (2005). Differential efficacy of probiotic species in amelioration of dextran sulphate sodium-induced colitis in rats. In GASTROENTEROLOGY Vol. 128 (pp. A603-A604). Chicago, IL: W B SAUNDERS CO.
WoS32005 Yazbek, R., Demuth, H. U., Geier, M. S., Abbott, C. A., & Howarth, G. S. (2005). Inhibition of dipeptidyl peptidase IV-like activity partially ameliorates development of experimentally-induced colitis in mice. In GASTROENTEROLOGY Vol. 128 (pp. A200). Chicago, IL: W B SAUNDERS CO. 2004 Geier, M., Abbott, C., Tenikoff, D., McCaughan, G., & Howarth, G. (2004). Development and resolution of experimental colitis in dipeptidyl peptidase IV knockout mice. In GASTROENTEROLOGY Vol. 126 (pp. A142). New Orleans, LA: W B SAUNDERS CO. 2004 Coldwell, J. R., Howarth, G. L., & Blackshaw, L. A. (2004). Colonic extraluminal mechanoreceptors and inflammation in the rat colon. In GASTROENTEROLOGY Vol. 126 (pp. A164). New Orleans, LA: W B SAUNDERS CO. 2004 Coldwell, J. R., Howarth, G. L., & Blackshaw, A. (2004). High threshold rat colonic afferents directly respond to mast cell degranulation in acute inflammation. In GASTROENTEROLOGY Vol. 126 (pp. A161). New Orleans, LA: W B SAUNDERS CO. 2004 Coldwell, J. R., Howarth, G. L., & Blackshaw, L. A. (2004). Increased colonic afferent sensitivity to 5-HT in inflammation and recovery. In GASTROENTEROLOGY Vol. 126 (pp. A94). New Orleans, LA: W B SAUNDERS CO. 2003 Cool, J. C., Seymour-Griffin, C. L., Geier, M. S., Tenikoff, D., Lee, S. S., Dang, Y. P., . . . Howarth, G. S. (2003). Temporal profile of repair and proliferation during recovery from indomethacin injury in the rat stomach. In GASTROENTEROLOGY Vol. 124 (pp. A174). ORLANDO, FLORIDA: W B SAUNDERS CO. 2003 Dyer, J. L., Butler, R. N., Xian, C. J., & Howarth, G. S. (2003). Partial attenuation of 5-fluorouracil (5-FU)-induced intestinal mucositis by pretreatment with insulin-like growth factor-I (IGF-I) in rats. In GASTROENTEROLOGY Vol. 124 (pp. A597). ORLANDO, FLORIDA: W B SAUNDERS CO.
DOI1999 Tran, C. P., Familari, M., Whitehead, R. H., & Giraud, A. S. (1999). Characterisation of a butyrate response element in the human trefoil factor 3 gene promoter. In GASTROENTEROLOGY Vol. 116 (pp. A940). W B SAUNDERS CO-ELSEVIER INC. 1998 Steeb, C. B., Shoubridge, C. A., Lamb, J., Howarth, G. S., & Read, L. C. (1998). Role of insulin-like growth factor-I in gastrointestinal growth and repair. In K. Takano, N. Hizuka, & S. I. Takahashi (Eds.), MOLECULAR MECHANISMS TO REGULATE THE ACTIVITIES OF INSULIN-LIKE GROWTH FACTORS Vol. 1151 (pp. 331-339). TOKYO, JAPAN: ELSEVIER SCIENCE BV. 1997 Xian, C. J., Mardell, C. E., & Read, L. C. (1997). Differential changes in immunoreactivity of TGF alpha and beta 1 in colonic mucosa in childhood inflammatory bowel disease. In GASTROENTEROLOGY Vol. 112 (pp. A1122). W B SAUNDERS CO-ELSEVIER INC. 1994 READ, L. C., HOWARTH, G. S., STEEB, C. B., & LEMMEY, A. B. (1994). IN-VIVO EFFECTS OF IGF-I ON GUT GROWTH AND FUNCTION. In R. C. Baxter, P. D. Gluckman, & R. G. Rosenfeld (Eds.), INSULIN-LIKE GROWTH FACTORS AND THEIR REGULATORY PROTEINS Vol. 1056 (pp. 409-416). SYDNEY, AUSTRALIA: ELSEVIER SCIENCE PUBL B V.
WoS11992 READ, L. C., HOWARTH, G. S., LEMMEY, A. B., STEEB, C., TRAHAIR, J., TOMAS, F. M., & BALLARD, F. J. (1992). THE GASTROINTESTINAL-TRACT - A MOST SENSITIVE TARGET FOR IGF-I. In G. P. Savage (Ed.), PROCEEDINGS OF THE NUTRITION SOCIETY OF NEW ZEALAND, VOL 17 Vol. 17 (pp. 38-44). MASSEY UNIV, PALMERSTON NORTH, NEW ZEALAND: NUTRITION SOC NEW ZEALAND. -
Conference Items
Currently held Competitive Grants
Title | Funding Body | Investigators | Years | Funds |
---|---|---|---|---|
New inhibitors of colon cancer development |
Oncology Research International |
G Howarth |
2016-2017 |
$126,000 |
Biomarker development to monitor disease progression in Huntington’s transgenic sheep | Brain Research New Zealand | G Howarth R Snell |
2016-2017 | $219,980 |
Currently held Industry Grants
Title | Funding Body | Investigators | Years | Funds |
---|---|---|---|---|
ZMG-Emu Oil and experimental colitis | Story Pharmaceuticals |
G Howarth |
2015 | $37,714 |
Past Support
Title | Funding Body | Investigators | Years | Funds |
---|---|---|---|---|
Insulin-like growth factors and treatment of gastric ulceration disease | CRC for Tissue Growth and Repair |
G Howarth |
1997-2002 | $700,000 |
Milk growth factors and treatment of experimental inflammatory bowel disease | Nutricia Inc |
G Howarth |
1997-1999 | $320,000 |
Whey growth factors and prevention of oral mucositis | R&D Syndicate |
L Read |
1995-1998 | $3.4 mill |
Milk-derived growth factors and treatment of intestinal mucositis | Mead-Johnson Inc Cephalon Inc |
L Read |
1993-1994 | $50,000 |
Effects of IGF-I on DSS-induced colonic carcinoma in rats | Anti-Cancer Foundation of South Australia |
G Howarth |
1995-1996 | $17,000 |
IGF-I effects on IBD-induced colon cancer |
Crohn’s and Colitis Association of South Australia Equipment Grant |
G Howarth |
1996 | $4,500 |
Whey growth factors and treatment of oral mucositis | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
1995-1996 | $20,000 |
Milk-derived growth factors and treatment of gastritis | CRC for Tissue Growth and Repair |
L Read |
1998-2003 | $700,000 |
Whey growth factor effects on ulcerative colitis |
Crohn’s and Colitis Association of South Australia (Equipment grant), |
G Howarth |
1999 | $2,500 |
Milk-derived growth factor formulations for treatment of gut immaturity and ulceration | Nestle Inc |
L Read |
2000-2002 | $800,000 |
Milk-derived growth factor formulations for treatment of gastric ulceration | Biotechnology Innovation Fund |
L Read |
2001-2003 | $500,000 |
The potential role of DPIV in inflammatory bowel disease | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
2003-2004 | $35,000 |
Development of a novel non-invasive test to monitor intestinal function | Biotechnology Innovation Fund |
R Butler |
2003-2005 | $498,000 |
Inhibitors of DPIV and treatment of inflammatory bowel disease | Channel 7 Children's Medical Research Foundation of South Australia |
G Howarth |
2004-2005 | $55,000 |
Folate-producing probiotics and amelioration of intestinal mucositis | Cancer Council SA |
G Howarth |
2005-2006 | $50,000 |
Research Fellowship | Cancer Council SA |
G Howarth |
2005-2008 | $250,000 |
Refurbishment of Small Animal House and installation of Metabolism caging |
University of Adelaide |
G Howarth |
2006 | $70,000 |
Spinosad and repair of chemotherapy-induced mucositis | Elanco Animal Services (Eli Lilly) |
G Howarth |
2006 | $20,000 |
New bioactive factors for treatment of HIV | Numico Pty Ltd |
R Butler |
2006-2007 | $120,000 |
Effects of increasing dietary fat content on carcass composition in pigs |
Pork CRC |
R Campbell |
2006 2007 2008 |
$20,000 $20,000 $20,000 |
Palifermin (KGF) and repair of chemotherapy-induced mucositis | Amgen Pty Ltd |
G Howarth |
2006-2008 | $80,000 |
Clinical trial of Lactermin for treatment of chemotherapy-induced mucositis |
Commercial Ready |
*Awarded to TGR BioSciences |
2006-2008 | *$1,300,000 |
Emu Oil : role in chemotherapy-induced mucositis and IBD | Emu Tracks |
G Howarth |
2007-2008 | $30,000 |
The extent of competition between the native and introduced herbivores of Kangaroo Island |
ARC |
P Stott |
2007 |
$35,000 |
Novel probiotics and naturally- sourced extracts as a treatment strategy for chemotherapy-induced intestinal mucositis |
Cancer Council SA |
G Howarth |
2008 | $82,750 |
Probiotic effects on chronic colonic inflammation and DNA methylation status during tumourigenesis | Cancer Council SA |
G Howarth |
2008 | $82,750 |
Evaluation of a novel nutraceutical from muricid molluscs as complementary medicine for gastrointestinal diseases | Bushell Foundation |
K Benkendorff |
2008 2009 |
$108,100 $105,000 |
Development of a new treatment for canine mucositis |
Nidor Pty Ltd/ BioIberica Inc |
G Howarth C Booton |
2009-2010 | $80,000 |
Novel probiotics and naturally-sourced extracts in chemotherapy-induced mucositis | Sally Birch Cancer Council Senior Research Fellowship in Cancer Control |
G Howarth |
2009 |
$100,000 |
Novel probiotics and naturally-sourced extracts in chemotherapy-induced mucositis | NHMRC Complementary Medicine |
G Howarth |
2008 |
$121,750 |
Emu Oil treatments for gastrointestinal disease | Rural Industries Research and Development Corporation | G Howarth |
2010 |
$120,000 |
Filamin A binding compounds and protection from intestinal disease | Pain Therapeutics Pty Ltd | G Howarth | 2012 | $30,000 |
Night camera video imaging for animal model behaviour studies | Faculty of Sciences |
G Howarth P Stott |
2013 | $8,700 |
Novel nutraceutical formulations for alleviation of chemotherapy-induced intestinal mucositis | SA Cancer Research Collaborative Fellowship | G Howarth |
2012 |
$105,000 |
Teaching Interests
Professor Howarth is the coordinator for the Laboratory Animal Science course that was introduced in the B Sc (Animal Science) program in 2007. Professor Howarth is a work experience student coordinator at the University and at the Women's and Children's Hospital. He also supervises groups of 3rd year Physiology students and DVM-1 students in research projects annually. Professor Howarth currently supervises 9 PhD students and two Honours students in his laboratory.
Postgraduate and Undergraduate Teaching
In addition to his position at the University of Adelaide, Professor Howarth has been appointed to affiliate academic positions in the other South Australian universities: the University of South Australia and Flinders University. These affiliations have considerably expanded his ability to attract quality students to his research group. Professor Howarth has also been actively involved in giving presentations to tertiary student bodies such as the Wilto Yerlo Centre for Australian Indigenous Research & Studies (2006).
Undergraduate Teaching
- Completed the University of Adelaide (Centre for Professional Learning and Certificate course: “Teaching at University (TaU)” [2005] Invited to present my work in the TaU course at the ‘Investigations into University Learning and Teaching’ Tri-institutional Symposium held in Adelaide (February 2006)
- Completed the introductory MyUni course at the University of Adelaide [2005]
- Participant in the ‘Twinning’ Program bridging Scientists with School Science Teachers [2004-Present].
- Commenced undergraduate lecturing at University of Adelaide (Roseworthy campus) [Animal Biotechnology] in February 2006.
- First student evaluation of teaching conducted in June 2008. Student Evaluation of Learning and Teaching (SELT) analysis resulted in the following scores (median responses) for the 3rd year Laboratory Animal Science course (91% responses).
- Evaluation rated from 1 (unsatisfactory) to 7 (outstanding)
- Effectiveness as a University teacher: SELT score = 6
- Organization of the teacher: SELT score = 6
- Concern for students: SELT score = 6
- Demonstrates enthusiasm for encouraging student learning: SELT score = 6
- Teacher encourages student participation: SELT score = 6
- Teacher stimulates my interest in learning in this course: SELT score = 5
- Teacher gives clear explanations: SELT score = 6
- eSELT score: Effectiveness as a teacher = 6 (2015)
- 2006-2008, Nutrition and Metabolism [3rd year BSc (An Sci)] Course Coordinator together with Ms Sarah Pain– Semester II
- 2007-Present, Laboratory Animal Science [3rd year BSc (An Sci)] Course Coordinator with Dr Sarah Pain (2007 and 2008); Dr Roger Yazbek (2009 and 2010); Dr Alexandra Whittaker (2011 to 2015)
Undergraduate Research Students
- 1999- Present, University of Adelaide, Discipline of Physiology (3rd year research Project students: 4 students/year)
- 2001- 2007, University of SA, School of Pharmaceutical and Biomedical Sciences (4th year Biotechnology students: 1-2 students for 3-months each year)
- 2000- Present, University of Adelaide, Faculty of Health Sciences (4th year research Project students: occasional student)
- 2000- Present, Flinders University, School of Biological Sciences (final year research projects occasional student)
- 2005, Ms Hanh Lam (Final-year student) Co-supervisor. Health Sciences, University of South Australia
- 2005, Ms Alvina Lim (Final-year student) Co-supervisor. Health Sciences, University of South Australia
- 2005, Ms Lisa Nicholas, Ms Lisa Philp, Ms Nivanee Nair, Ms Jane Chapman, Ms Kelly Roberts and Ms Cassie Smith. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2006, Ms Kim Maiolo, Ms Eugenie Lim, Ms Kris Hyang, Ms Grace Chan, Ms Shervi Lie, Ms Flavia Lee. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2007, Ms Miranda Leach, Ms Annika Wendland, Ms Rachel Jennings, Ms Suzanne Mashtoub. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2008, Ms Xiao Dan Ding, Ms Megan Vu, Ms Masooma Sultani, Mr Bang Hoang. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2009, Mr James Milosh, Ms Jessica Ryan, Ms Ellen Musolino. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2010, Ms Ella Bourne, Ms Kristen Brown, Ms Christine Nguyen, Mr James Selby. 3rd Year Physiology Research Project students. Sole supervisor. Dept of Physiology, University of Adelaide
- 2011, Ms Jessica Panini, Ms Zahra Lotfollahi, Mr Damiano Stomaci, Mr Liam Hoyle, Ms Elaine Penascoza. 3rd Year Physiology Research Project students. Co-supervisor (with PhD student, Ms Suzanne Abimosleh). Dept of Physiology, University of Adelaide
- 2012, Ms Juliana Bajic, Ms Elaine Penascoza. 3rd Year Physiology Project students. Co-supervisor (with PhD student, Ms Suzanne Abimosleh). Dept of Physiology, University of Adelaide
- 2013, Mr Karl Ramsden, Ms Imogen Abernethy, Ms Erica Freitas Lima Lemos. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Roger Yazbek). Dept of Physiology, University of Adelaide
- 2014, Ms Dania Ruminski-Smith, Ms Lauren Chartier, Mr Scott Barker, Ms Hana Seo, Ms Romina Ghaemi, Ms Jacinta Fong. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Suzanne Mashtoub). Dept of Physiology, University of Western Australia
- 2015, Ms Jacqueline Edwards, Ms Rosa Harmer, Ms Yunsi Lei, Ms Samantha Perera. Ms Jessica Flavel. 3rd Year Physiology Research Project students. Co-supervisor (with post-doc, Dr Suzanne Mashtoub). Dept of Physiology, University of Western Australia
Vacation Scholarship Students (6-8 week summer placements)
- 1998, Ms Fiona Clark (School of Biological Sciences, Flinders University)
- 1999, Ms Olgatina Bucco (Discipline of Physiology, University of Adelaide)
- 2001, Mr Adrian Liston (Discipline of Physiology, University of Adelaide)
- 2002, Ms Katy Ramsden (Discipline of Physiology, University of Adelaide)
- 2003, Ms Rasha Kamil (Discipline of Physiology, University of Adelaide)
- 2005, Ms Swagatha Sundar (School of Pharmacy and Medical Science, University of South Australia)
- 2005, Mr Simon Moretta (School of Pharmacy and Medical Science, University of South Australia)
- 2006, Ms Lauren Savage (School of Agriculture, Food and Wine, University of Adelaide)
- 2006, Ms Amanda McLean (School of Agriculture, Food and Wine, University of Adelaide)
- 2009, Ms Caitlin Brook (School of Animal and Veterinary Sciences, University of Adelaide)
- 2010, Ms Andrea Fernandez (School of Medical Sciences, University of Adelaide)
- 2011, Ms Zahra Lotfollahi (School of Medical Sciences, University of Adelaide)
- 2012, Mr Brett Lange (School of Animal and Veterinary Sciences, University of Adelaide)
- 2014, Ms Farrah Preston (School of Animal and Veterinary Sciences, University of Adelaide)
- 2015, Ms Amy Bates and Ms Georgia Wallace (School of Animal and Veterinary Sciences, University of Adelaide)
International Research Students (6-8 week placements)
- 2010, Mr Loic Antoine (Ecole Nationale Veterinaire, Toulouse, France)
- 2010, Mr Baptiste Pouchan (Ecole Nationale Veterinaire, Toulouse, France)
Previous Postgraduate Student Training (with resulting peer-reviewed publications)
- 1983, Dr Jane Lomax-Smith (FRCPA and PhD, with Dr Andrew Woodroffe)
- 1983, Dr Amanda Gramp (FRCPA, with Professor Barrie Vernon-Roberts)
- 1984, Dr Kym Bannister (MD, with Dr Andrew Woodroffe)
- 1993, Ms Karen Ribbons (PhD, with Dr Leanna Read)
- 1994, Mr Andrew Lemmey (PhD, with Dr Leanna Read)
- 1995, Mr Michael Conlon (PhD, with Dr Frank Tomas)
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2024 Co-Supervisor Clinical trial of orally-administered Emu Oil in children with ulcerative colitis. Doctor of Philosophy Doctorate Full Time Ms Sisanda Nomcebo Mhlanga -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2017 - 2021 Principal Supervisor Emu Oil in Combination with Herbal Preparations Provides a Novel Adjunctive Approach to Colitis-Associated Colorectal Cancer Prevention Doctor of Philosophy Doctorate Full Time Miss Lauren Claire Chartier 2016 - 2021 Principal Supervisor An Investigation into Neuroimmune, Cognitive and Affective Behaviour after Chemotherapy Exposure in a Rat Model: Implications for Chemotherapy-induced Gut Toxicity and 'Chemobrain' Doctor of Philosophy Doctorate Full Time Dr Rebecca Peta George 2016 - 2022 Co-Supervisor PROMOTION OF CRYPT FISSION BY THE WNT-b-CATENIN SIGNALLING PATHWAY IN HUMANS AND RATS Doctor of Philosophy Doctorate Full Time Mrs Zenab Mustansir Dudhwala 2015 - 2018 Principal Supervisor Analysis of the Judgement Bias Test for Welfare Assessment in Rats Doctor of Philosophy Doctorate Full Time Mr Timothy Hugh Barker 2015 - 2022 Principal Supervisor Thermoregulation in exercising horses: Aspects of temperature monitoring during field exercise Doctor of Philosophy under a Jointly-awarded Degree Agreement with Doctorate Part Time Dr Lidwien Verdegaal 2015 - 2018 Co-Supervisor Antimicrobial resistance in companion animal pathogens in Australia and assessment of pradofloxacin on the gut microbiota Doctor of Philosophy Doctorate Full Time Mr Sugiyono Saputra 2014 - 2017 Principal Supervisor Biomarkers of Increased Intestinal Permeability in Chickens Doctor of Philosophy Doctorate Full Time Mr Saad Gilani 2014 - 2019 Co-Supervisor From the Bottom Up: Chemotherapy-Induced Gut Toxicity, Glial Reactivity and Cognitive Impairment Doctor of Philosophy Doctorate Part Time Dr Juliana Esma Bajic 2012 - 2016 Principal Supervisor Probiotic-Derived Factors as Potential Chemopreventive Agents for Intestinal Mucositis and Colon Cancer Doctor of Philosophy Doctorate Full Time Miss Hanru Wang 2012 - 2017 Principal Supervisor Naturally-Fermented Milk from Indonesia: A Study of Microbial Diversity and Probiotic Potency for the Potential Treatment of Intestinal Mucositis Doctor of Philosophy Doctorate Full Time Mr Yoga Dwi Jatmiko 2011 - 2012 Co-Supervisor A Test of the Hutchinson Theory of Interspecific Competition Doctor of Philosophy Doctorate Full Time Mr Richard Bosworth 2011 - 2016 Principal Supervisor Evaluation of Indices of Affective State in a Rat Model of Chemotherapy-induced Mucositis Doctor of Philosophy Doctorate Part Time APrf Alexandra Whittaker 2010 - 2013 Principal Supervisor Emu Oil Promotes Intestinal Repair in Rat Models of Enteric Inflammation Doctor of Philosophy Doctorate Full Time Dr Suzanne Mashtoub 2008 - 2016 Principal Supervisor Heat Stress in Racing Greyhounds Doctor of Philosophy Doctorate Part Time Ms Jane McNicholl 2008 - 2012 Co-Supervisor Grape Sourced Bioactives: A Potential New Treatment Strategy for Intestinal Mucositis and Colon Cancer Doctor of Philosophy Doctorate Full Time Miss Ker Yeaw Cheah 2008 - 2013 Principal Supervisor Probiotic-Derived Factors for the Treatment and Prevention of 5-Fluorouracil-Induced Intestinal Mucositis Doctor of Philosophy Doctorate Full Time Mr Luca Prisciandaro 2006 - 2007 Principal Supervisor An in vivo Model to Study Mucin-bacterial Interactions During Early Post-hatch Development of Broiler Chickens Doctor of Philosophy Doctorate Full Time Dr Bec Forder 2006 - 2013 Principal Supervisor Medium Chain Fatty Acids and Wnt/B-Catenin Inhibitors as Adjunctive Colorectal Cancer Chemotherapeutic Agents Doctor of Philosophy Doctorate Full Time Ms Jane Fauser 2004 - 2007 Principal Supervisor Probiotics and Prebiotics as a Therapeutic Strategy for Inflammatory Bowel Disease Doctor of Philosophy Doctorate Part Time Dr Mark Geier 2004 - 2007 Co-Supervisor Short-Chain Fatty Acid Modulation of Apoptosis in Gastric and Colon Cancer Cells' Doctor of Philosophy Doctorate Full Time Mr Geoffrey Matthews 2003 - 2007 Co-Supervisor Detection of Small Intestinal Mucositis Utilising the Non-Invasive 13 C-Sucrose Breath Test' Doctor of Philosophy Doctorate Part Time Mrs Katie Tooley
-
Committee Memberships
Date Role Committee Institution Country 2016 - 2016 Chair Program Management Committee: Animal Science University of Adelaide Australia 2015 - ongoing Member Research and Educational Development Committee University of Adelaide Australia 2015 - ongoing Member Welfare, Health and Safety Committee - SAVS University of Adelaide Austria 2015 - ongoing Chair Faculty HDR Committee University of Adelaide Australia 2014 - ongoing Chair Research Committee - School of Animal and Veterinary Sciences University of Adelaide Australia 2014 - ongoing Member Faculty of Sciences Research Committee University of Adelaide Australia 2013 - ongoing Member Executive Committee - School of Animal and Veterinary Sciences University of Adelaide Australia 2008 - ongoing Co-Chair HDR/Honours Committee - School of Animal and Veterinary Sciences University of Adelaide Australia 2006 - ongoing Founder University Institutional Biosafety Committee University of Adelaide Australia -
Editorial Boards
Date Role Editorial Board Name Institution Country 2013 - 2018 Editor-In-chief Advances in Veterinary Science Research Global Science and technology Foundation Singapore 2004 - ongoing Associate Editor Journal of Nutrition and Metabolism - United States
Connect With Me
External Profiles